United States Biotechnology & Medical Research

Candel Therapeutics Inc (CADL)

Track

Track

Candel Therapeutics Inc. experienced significant insider trading activity recently, characterized by substantial planned and proposed sales. CEO Paul Peter Tak executed major divestments totaling over ten million dollars. These transactions follow a disappointing August earnings report, where the company missed EPS expectations by nearly sixty percent, occurring while shares trade near their annual lows.
Ticker: CADL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Candel Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
301.95
Quantity 74,007 -34.6%
Value US$883,075
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
477.10
Quantity 37,665 -14.5%
Value US$4,688,275
2.9
PAUL PETER TAK Director; Officer Executive Director
Transaction date
Proposed sale
Price
301.62
Quantity 42,233
Value US$783,707
2.9
PAUL PETER TAK Director; Officer Executive Director
Transaction date
Proposed sale
Price
12.17
Quantity 280,245
Value US$3,410,582
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Planned sale
Price
12.00
Quantity 7,000 -8.3%
Value US$84,000
3.3
SESHU TYAGARAJAN Officer Officer
Transaction date
Proposed sale
Price
11.72
Quantity 7,000
Value US$82,040
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Planned sale
Price
10.02
Quantity 7,000 -7.7%
Value US$70,151
3.0
Barone Francesca Chief Scientific Officer Officer
Transaction date
Planned sale
Price
10.06
Quantity 23,447 -23.3%
Value US$235,769
3.3
SESHU P TYAGARAJAN Officer Officer
Transaction date
Proposed sale
Price
9.79
Quantity 7,000
Value US$68,530
3.0
FRANCESCA BARONE Officer Officer
Transaction date
Proposed sale
Price
9.79
Quantity 23,447
Value US$229,546
4.0
Manning Paul B Non-Executive Director
Transaction date
Purchase
Price
5.45
Quantity 550,458 +24.9%
Value US$2,999,996
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.98
Quantity 937 -1.8%
Value US$6,540
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.04
Quantity 781 -1.5%
Value US$3,936
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
9.00
Quantity 400 -0.2%
Value US$3,601
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.76
Quantity 45,316 -46.3%
Value US$396,995
3.0
Barone Francesca Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.76
Quantity 32,146 -25.0%
Value US$281,673
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
8.77
Quantity 25,772 -10.2%
Value US$226,023
3.0
FRANCESCA BARONE Officer Officer
Transaction date
Proposed sale
Price
8.83
Quantity 32,146
Value US$283,849
2.9
PAUL PETER TAK Director; Officer Executive Director
Transaction date
Proposed sale
Price
8.83
Quantity 74,106
Value US$654,356
3.0
WILLIAM GARRETT NICHOLS Officer Officer
Transaction date
Proposed sale
Price
8.83
Quantity 45,316
Value US$400,140
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Planned sale
Price
8.82
Quantity 31,278 -26.8%
Value US$275,947
3.2
Schoch Charles See Remarks Officer
Transaction date
Planned sale
Price
8.83
Quantity 5,000 -11.6%
Value US$44,169
3.3
SESHU TYAGARAJAN Officer Officer
Transaction date
Proposed sale
Price
8.75
Quantity 31,278
Value US$273,682
3.2
CHARLES SCHOCH Officer Officer
Transaction date
Proposed sale
Price
8.75
Quantity 5,000
Value US$43,750
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Sale
Price
7.23
Quantity 14,322 -12.9%
Value US$103,476
3.2
Schoch Charles See Remarks Officer
Transaction date
Sale
Price
7.23
Quantity 9,511 -18.1%
Value US$68,717
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
7.23
Quantity 21,704 -7.9%
Value US$156,811
3.0
Barone Francesca Chief Scientific Officer Officer
Transaction date
Sale
Price
7.23
Quantity 13,534 -10.9%
Value US$97,783
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Sale
Price
7.23
Quantity 10,428 -11.6%
Value US$75,342
3.3
Tyagarajan Seshu Officer Officer
Transaction date
Proposed sale
Price
7.84
Quantity 13,177
Value US$103,308
3.0
Nichols William Garrett Officer Officer
Transaction date
Proposed sale
Price
7.86
Quantity 9,564
Value US$75,217
3.0
Barone Francesca Officer Officer
Transaction date
Proposed sale
Price
7.84
Quantity 12,452
Value US$97,624
3.2
Schoch Charles Officer Officer
Transaction date
Proposed sale
Price
7.84
Quantity 8,751
Value US$68,608
2.9
Tak Paul Peter Officer; Director Executive Director
Transaction date
Proposed sale
Price
7.84
Quantity 19,970
Value US$156,565
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
8.22
Quantity 21,172 -7.2%
Value US$173,996
3.2
Schoch Charles See Remarks Officer
Transaction date
Sale
Price
8.22
Quantity 9,971 -15.9%
Value US$81,944
3.0
Barone Francesca Chief Scientific Officer Officer
Transaction date
Sale
Price
8.22
Quantity 13,673 -9.9%
Value US$112,367
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Sale
Price
8.22
Quantity 14,545 -11.6%
Value US$119,534
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Sale
Price
8.22
Quantity 10,799 -10.7%
Value US$88,749
3.3
Tyagarajan Seshu Officer Officer
Transaction date
Proposed sale
Price
8.35
Quantity 14,297
Value US$119,380
2.9
Tak Paul Peter Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.35
Quantity 20,811
Value US$173,772
3.0
Barone Francesca Officer Officer
Transaction date
Proposed sale
Price
8.35
Quantity 13,440
Value US$112,224
3.2
Schoch Charles Officer Officer
Transaction date
Proposed sale
Price
8.35
Quantity 9,801
Value US$81,838
4.0
Manning Paul B Non-Executive Director
Transaction date
Purchase
Price
6.00
Quantity 750,000 +135.4%
Value US$4,500,000
4.0
Manning Paul B Non-Executive Director
Transaction date
Purchase
Price
6.00
Quantity 500,000 +77.8%
Value US$3,000,000
3.0
Barone Francesca Chief Scientific Officer Officer
Transaction date
Sale
Price
4.56
Quantity 22,081 -13.8%
Value US$100,592
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Sale
Price
4.56
Quantity 13,935 -12.2%
Value US$63,482
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.56
Quantity 48,847 -14.2%
Value US$222,527
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Sale
Price
4.56
Quantity 20,392 -14.0%
Value US$92,898
3.3
Tyagarajan Seshu Officer Officer
Transaction date
Proposed sale
Price
4.95
Quantity 18,548
Value US$91,813
2.9
Tak Paul Peter Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.95
Quantity 44,433
Value US$219,943
3.0
Nichols William Garrett Officer Officer
Transaction date
Proposed sale
Price
4.95
Quantity 12,675
Value US$62,741
3.0
Barone Francesca Officer Officer
Transaction date
Proposed sale
Price
4.95
Quantity 20,085
Value US$99,421
1.9
Aguilar-Cordova Estuardo Large shareholder
Transaction date
Sale
Price
6.03
Quantity 10,412 -1.1%
Value US$62,784
1.9
Aguilar-Cordova Estuardo Large shareholder
Transaction date
Sale
Price
6.02
Quantity 15,000 -1.6%
Value US$90,300
1.9
Aguilar-Cordova Estuardo Large shareholder
Transaction date
Sale
Price
6.05
Quantity 15,000 -1.6%
Value US$90,750
1.9
Aguilar-Cordova Estuardo Large shareholder
Transaction date
Sale
Price
6.85
Quantity 1,800 -0.2%
Value US$12,330
1.9
Aguilar-Cordova Estuardo Large shareholder
Transaction date
Sale
Price
6.92
Quantity 26,988 -2.7%
Value US$186,757
1.9
Aguilar-Cordova Estuardo Director Non-Executive Director
Transaction date
Proposed sale
Price
7.00
Quantity 28,480
Value US$199,360
1.9
Aguilar-Cordova Estuardo Director Non-Executive Director
Transaction date
Proposed sale
Price
6.50
Quantity 28,840
Value US$187,460
3.0
Barone Francesca Chief Scientific Officer Officer
Transaction date
Sale
Price
6.47
Quantity 14,051 -8.1%
Value US$90,947
3.2
Schoch Charles See Remarks Officer
Transaction date
Sale
Price
6.47
Quantity 9,884 -13.7%
Value US$63,975
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
6.47
Quantity 22,528 -6.4%
Value US$145,815
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Sale
Price
6.47
Quantity 14,851 -9.2%
Value US$96,125
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Sale
Price
6.47
Quantity 10,875 -8.7%
Value US$70,390
3.3
Tyagarajan Seshu Officer Officer
Transaction date
Proposed sale
Price
7.29
Quantity 13,164
Value US$95,966
2.9
Tak Paul Peter Officer; Director Executive Director
Transaction date
Proposed sale
Price
7.29
Quantity 19,970
Value US$145,581
3.2
Schoch Charles Officer Officer
Transaction date
Proposed sale
Price
7.29
Quantity 8,761
Value US$63,868
3.0
Nichols William Garrett Officer Officer
Transaction date
Proposed sale
Price
7.29
Quantity 9,640
Value US$70,276
3.0
Barone Francesca Officer Officer
Transaction date
Proposed sale
Price
7.29
Quantity 12,455
Value US$90,797
3.3
Tyagarajan Seshu Chief Technology Officer Officer
Transaction date
Sale
Price
5.97
Quantity 13,330 -7.7%
Value US$79,625
2.9
Tak Paul Peter Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.97
Quantity 20,293 -5.4%
Value US$121,218
3.0
Nichols William Garrett Chief Medical Officer Officer
Transaction date
Sale
Price
5.97
Quantity 9,769 -7.2%
Value US$58,354
3.2
Schoch Charles See Remarks Officer
Transaction date
Sale
Price
5.97
Quantity 8,897 -10.9%
Value US$53,145
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-11 2026-09-11 PlS Planned sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
74,007 -34.6%
301.95
US$883,075 		74,007 -34.6% 301.95 US$883,075
2026-09-11 2026-09-10 PlS Planned sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
37,665 -14.5%
477.10
US$4,688,275 		37,665 -14.5% 477.10 US$4,688,275
2026-09-10 2026-09-10 PrS Proposed sale
2.9
PAUL PETER TAK

Director; Officer

Executive Director
42,233
301.62
US$783,707 		42,233 301.62 US$783,707
2026-09-10 2026-09-10 PrS Proposed sale
2.9
PAUL PETER TAK

Director; Officer

Executive Director
280,245
12.17
US$3,410,582 		280,245 12.17 US$3,410,582
2026-08-19 2026-08-17 PlS Planned sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
7,000 -8.3%
12.00
US$84,000 		7,000 -8.3% 12.00 US$84,000
2026-08-17 2026-08-17 PrS Proposed sale
3.3
SESHU TYAGARAJAN

Officer

Officer
7,000
11.72
US$82,040 		7,000 11.72 US$82,040
2026-07-01 2026-06-29 PlS Planned sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
7,000 -7.7%
10.02
US$70,151 		7,000 -7.7% 10.02 US$70,151
2026-07-01 2026-06-29 PlS Planned sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
23,447 -23.3%
10.06
US$235,769 		23,447 -23.3% 10.06 US$235,769
2026-06-29 2026-06-29 PrS Proposed sale
3.3
SESHU P TYAGARAJAN

Officer

Officer
7,000
9.79
US$68,530 		7,000 9.79 US$68,530
2026-06-29 2026-06-29 PrS Proposed sale
3.0
FRANCESCA BARONE

Officer

Officer
23,447
9.79
US$229,546 		23,447 9.79 US$229,546
2026-02-26 2026-02-23 B Purchase
4.0
Manning Paul B
Non-Executive Director
550,458 +24.9%
5.45
US$2,999,996 		550,458 +24.9% 5.45 US$2,999,996
2025-07-30 2025-07-28 PlS Planned sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
937 -1.8%
6.98
US$6,540 		937 -1.8% 6.98 US$6,540
2025-07-02 2025-06-30 PlS Planned sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
781 -1.5%
5.04
US$3,936 		781 -1.5% 5.04 US$3,936
2025-03-20 2025-03-19 PlS Planned sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
400 -0.2%
9.00
US$3,601 		400 -0.2% 9.00 US$3,601
2025-03-20 2025-03-18 PlS Planned sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
45,316 -46.3%
8.76
US$396,995 		45,316 -46.3% 8.76 US$396,995
2025-03-20 2025-03-18 PlS Planned sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
32,146 -25.0%
8.76
US$281,673 		32,146 -25.0% 8.76 US$281,673
2025-03-20 2025-03-18 PlS Planned sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
25,772 -10.2%
8.77
US$226,023 		25,772 -10.2% 8.77 US$226,023
2025-03-18 2025-03-18 PrS Proposed sale
3.0
FRANCESCA BARONE

Officer

Officer
32,146
8.83
US$283,849 		32,146 8.83 US$283,849
2025-03-18 2025-03-18 PrS Proposed sale
2.9
PAUL PETER TAK

Director; Officer

Executive Director
74,106
8.83
US$654,356 		74,106 8.83 US$654,356
2025-03-18 2025-03-18 PrS Proposed sale
3.0
WILLIAM GARRETT NICHOLS

Officer

Officer
45,316
8.83
US$400,140 		45,316 8.83 US$400,140
2025-03-19 2025-03-17 PlS Planned sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
31,278 -26.8%
8.82
US$275,947 		31,278 -26.8% 8.82 US$275,947
2025-03-19 2025-03-17 PlS Planned sale
3.2
Schoch Charles

See Remarks

Officer
5,000 -11.6%
8.83
US$44,169 		5,000 -11.6% 8.83 US$44,169
2025-03-17 2025-03-17 PrS Proposed sale
3.3
SESHU TYAGARAJAN

Officer

Officer
31,278
8.75
US$273,682 		31,278 8.75 US$273,682
2025-03-17 2025-03-17 PrS Proposed sale
3.2
CHARLES SCHOCH

Officer

Officer
5,000
8.75
US$43,750 		5,000 8.75 US$43,750
2025-01-17 2025-01-15 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
14,322 -12.9%
7.23
US$103,476 		14,322 -12.9% 7.23 US$103,476
2025-01-17 2025-01-15 S Sale
3.2
Schoch Charles

See Remarks

Officer
9,511 -18.1%
7.23
US$68,717 		9,511 -18.1% 7.23 US$68,717
2025-01-17 2025-01-15 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
21,704 -7.9%
7.23
US$156,811 		21,704 -7.9% 7.23 US$156,811
2025-01-17 2025-01-15 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
13,534 -10.9%
7.23
US$97,783 		13,534 -10.9% 7.23 US$97,783
2025-01-17 2025-01-15 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
10,428 -11.6%
7.23
US$75,342 		10,428 -11.6% 7.23 US$75,342
2025-01-15 2025-01-15 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
13,177
7.84
US$103,308 		13,177 7.84 US$103,308
2025-01-15 2025-01-15 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
9,564
7.86
US$75,217 		9,564 7.86 US$75,217
2025-01-15 2025-01-15 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
12,452
7.84
US$97,624 		12,452 7.84 US$97,624
2025-01-15 2025-01-15 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
8,751
7.84
US$68,608 		8,751 7.84 US$68,608
2025-01-15 2025-01-15 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
19,970
7.84
US$156,565 		19,970 7.84 US$156,565
2025-01-10 2025-01-08 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
21,172 -7.2%
8.22
US$173,996 		21,172 -7.2% 8.22 US$173,996
2025-01-10 2025-01-08 S Sale
3.2
Schoch Charles

See Remarks

Officer
9,971 -15.9%
8.22
US$81,944 		9,971 -15.9% 8.22 US$81,944
2025-01-10 2025-01-08 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
13,673 -9.9%
8.22
US$112,367 		13,673 -9.9% 8.22 US$112,367
2025-01-10 2025-01-08 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
14,545 -11.6%
8.22
US$119,534 		14,545 -11.6% 8.22 US$119,534
2025-01-10 2025-01-08 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
10,799 -10.7%
8.22
US$88,749 		10,799 -10.7% 8.22 US$88,749
2025-01-08 2025-01-08 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
14,297
8.35
US$119,380 		14,297 8.35 US$119,380
2025-01-08 2025-01-08 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
20,811
8.35
US$173,772 		20,811 8.35 US$173,772
2025-01-08 2025-01-08 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
10,614
8.35
US$88,627 		10,614 8.35 US$88,627
2025-01-08 2025-01-08 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
13,440
8.35
US$112,224 		13,440 8.35 US$112,224
2025-01-08 2025-01-08 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
9,801
8.35
US$81,838 		9,801 8.35 US$81,838
2024-12-18 2024-12-16 B Purchase
4.0
Manning Paul B
Non-Executive Director
750,000 +135.4%
6.00
US$4,500,000 		750,000 +135.4% 6.00 US$4,500,000
2024-12-18 2024-12-16 B Purchase
4.0
Manning Paul B
Non-Executive Director
500,000 +77.8%
6.00
US$3,000,000 		500,000 +77.8% 6.00 US$3,000,000
2024-12-03 2024-11-29 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
22,081 -13.8%
4.56
US$100,592 		22,081 -13.8% 4.56 US$100,592
2024-12-03 2024-11-29 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
13,935 -12.2%
4.56
US$63,482 		13,935 -12.2% 4.56 US$63,482
2024-12-03 2024-11-29 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
48,847 -14.2%
4.56
US$222,527 		48,847 -14.2% 4.56 US$222,527
2024-12-03 2024-11-29 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
20,392 -14.0%
4.56
US$92,898 		20,392 -14.0% 4.56 US$92,898
2024-11-29 2024-11-29 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
18,548
4.95
US$91,813 		18,548 4.95 US$91,813
2024-11-29 2024-11-29 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
44,433
4.95
US$219,943 		44,433 4.95 US$219,943
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
12,675
4.95
US$62,741 		12,675 4.95 US$62,741
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
20,085
4.95
US$99,421 		20,085 4.95 US$99,421
2024-10-15 2024-10-15 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
10,412 -1.1%
6.03
US$62,784 		10,412 -1.1% 6.03 US$62,784
2024-10-15 2024-10-14 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
15,000 -1.6%
6.02
US$90,300 		15,000 -1.6% 6.02 US$90,300
2024-10-15 2024-10-11 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
15,000 -1.6%
6.05
US$90,750 		15,000 -1.6% 6.05 US$90,750
2024-10-03 2024-10-03 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
1,800 -0.2%
6.85
US$12,330 		1,800 -0.2% 6.85 US$12,330
2024-10-03 2024-10-02 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
26,988 -2.7%
6.92
US$186,757 		26,988 -2.7% 6.92 US$186,757
2024-09-23 2024-09-23 PrS Proposed sale
1.9
Aguilar-Cordova Estuardo

Director

Non-Executive Director
28,480
7.00
US$199,360 		28,480 7.00 US$199,360
2024-09-13 2024-09-13 PrS Proposed sale
1.9
Aguilar-Cordova Estuardo

Director

Non-Executive Director
28,840
6.50
US$187,460 		28,840 6.50 US$187,460
2024-07-19 2024-07-17 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
14,051 -8.1%
6.47
US$90,947 		14,051 -8.1% 6.47 US$90,947
2024-07-19 2024-07-17 S Sale
3.2
Schoch Charles

See Remarks

Officer
9,884 -13.7%
6.47
US$63,975 		9,884 -13.7% 6.47 US$63,975
2024-07-19 2024-07-17 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
22,528 -6.4%
6.47
US$145,815 		22,528 -6.4% 6.47 US$145,815
2024-07-19 2024-07-17 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
14,851 -9.2%
6.47
US$96,125 		14,851 -9.2% 6.47 US$96,125
2024-07-19 2024-07-17 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
10,875 -8.7%
6.47
US$70,390 		10,875 -8.7% 6.47 US$70,390
2024-07-17 2024-07-17 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
13,164
7.29
US$95,966 		13,164 7.29 US$95,966
2024-07-17 2024-07-17 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
19,970
7.29
US$145,581 		19,970 7.29 US$145,581
2024-07-17 2024-07-17 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
8,761
7.29
US$63,868 		8,761 7.29 US$63,868
2024-07-17 2024-07-17 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
9,640
7.29
US$70,276 		9,640 7.29 US$70,276
2024-07-17 2024-07-17 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
12,455
7.29
US$90,797 		12,455 7.29 US$90,797
2024-07-15 2024-07-11 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
13,330 -7.7%
5.97
US$79,625 		13,330 -7.7% 5.97 US$79,625
2024-07-15 2024-07-11 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
20,293 -5.4%
5.97
US$121,218 		20,293 -5.4% 5.97 US$121,218
2024-07-15 2024-07-11 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
9,769 -7.2%
5.97
US$58,354 		9,769 -7.2% 5.97 US$58,354
2024-07-15 2024-07-11 S Sale
3.2
Schoch Charles

See Remarks

Officer
8,897 -10.9%
5.97
US$53,145 		8,897 -10.9% 5.97 US$53,145
Explore more

More insider trading research around Candel Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America